Solara Active Pharma Sciences Ltd.

₹478.15

-5.2 (-1.1%)

SOLARA Share Price

Pharmaceuticals & Biotechnology

As on April 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 2,104 Cr

P/E Ratio3562.97

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	485.32	Bearish
10-DMA	488.43	Bearish
20-DMA	478.14	Bullish
50-DMA	467.88	Bullish
100-DMA	508.02	Bearish
200-DMA	563.22	Bearish

Historical Performance

1 Year

-7.1%

3 Years

37.8%

5 Years

-65.4%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	12,838	12,889	14,438	12,683	16,169
Total Expenditure	10,775	13,841	13,099	11,884	12,310
Other Income	83	54	225	200	288
Operating Profit	2,146	-898	1,564	1,000	4,146
Interest	1,148	1,051	901	753	845
Depreciation	992	1,033	1,112	1,123	1,087
Profit Before Tax	5	-4,884	-448	-911	2,215
Consolidated Net Profit	5	-5,674	-222	-582	2,214
Adjusted EPS	---	-145	-6	-15	57

Compounded Sales Growth

10 Years:19.8

5 Years:-0.6

3 Years:0.2

TTM:-0.1

Compounded Profit Growth

10 Years:7.5

5 Years:-65.8

3 Years:-68.3

TTM:-79.9

Stock Price CAGR

10 Years:N/A

5 Years:-19.2

3 Years:11.3

TTM:-6.8

Return on Equity

10 Years:N/A

5 Years:56.8

3 Years:-5.7

last year:0.1

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	402	360	360	360	359
Total Reserves	10,507	8,963	14,632	14,879	15,488
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	1,908	1,715	2,171	2,992	2,065
Other Current Liabilities	1,203	1,675	1,444	1,738	1,166
Short Term Borrowings	5,729	7,603	6,488	6,099	3,609
Total Liabilities	22,318	23,510	28,207	28,898	25,880
Capital Work in Progress	2,800	2,564	2,385	2,386	880
Long Term Loans & Advances	275	238	285	546	592
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	516	524	603	1,089	73
Total Current Assets	7,287	7,881	11,875	12,393	10,576
Total Assets	22,318	23,510	28,207	28,898	25,880
Adjusted Book Value	271	239	384	423	441

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 3562.97, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a moderate 3-year price CAGR of 10.7%, reflecting average market performance.
The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹2146 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹12838 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 932248

No. of Shares: 1950 (Approx)

Performance:-6.8%

P/L: ₹-67752

NIFTY Performance: -1.4%

1 day Top Gainers